Cargando…
Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project
ABSTRACT: Inflammation is part of numerous pathological conditions, which are lacking satisfying treatment and effective concepts of prevention. A national research network project, DNTI, involving scientists from six Austrian universities as well as several external partners aimed to identify and c...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785209/ https://www.ncbi.nlm.nih.gov/pubmed/27069281 http://dx.doi.org/10.1007/s00706-015-1653-y |
_version_ | 1782420363570839552 |
---|---|
author | Waltenberger, Birgit Atanasov, Atanas G. Heiss, Elke H. Bernhard, David Rollinger, Judith M. Breuss, Johannes M. Schuster, Daniela Bauer, Rudolf Kopp, Brigitte Franz, Chlodwig Bochkov, Valery Mihovilovic, Marko D. Dirsch, Verena M. Stuppner, Hermann |
author_facet | Waltenberger, Birgit Atanasov, Atanas G. Heiss, Elke H. Bernhard, David Rollinger, Judith M. Breuss, Johannes M. Schuster, Daniela Bauer, Rudolf Kopp, Brigitte Franz, Chlodwig Bochkov, Valery Mihovilovic, Marko D. Dirsch, Verena M. Stuppner, Hermann |
author_sort | Waltenberger, Birgit |
collection | PubMed |
description | ABSTRACT: Inflammation is part of numerous pathological conditions, which are lacking satisfying treatment and effective concepts of prevention. A national research network project, DNTI, involving scientists from six Austrian universities as well as several external partners aimed to identify and characterize natural products capable of combating inflammatory processes specifically in the cardiovascular system. The combined use of computational techniques with traditional knowledge, high-tech chemical analysis and synthesis, and a broad range of in vitro, cell-based, and in vivo pharmacological models led to the identification of a series of promising anti-inflammatory drug lead candidates. Mechanistic studies contributed to a better understanding of their mechanism of action and delivered new knowledge on the molecular level of inflammatory processes. Herein, the used approaches and selected highlights of the results of this interdisciplinary project are presented. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-4785209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-47852092016-04-09 Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project Waltenberger, Birgit Atanasov, Atanas G. Heiss, Elke H. Bernhard, David Rollinger, Judith M. Breuss, Johannes M. Schuster, Daniela Bauer, Rudolf Kopp, Brigitte Franz, Chlodwig Bochkov, Valery Mihovilovic, Marko D. Dirsch, Verena M. Stuppner, Hermann Monatsh Chem Invited Review ABSTRACT: Inflammation is part of numerous pathological conditions, which are lacking satisfying treatment and effective concepts of prevention. A national research network project, DNTI, involving scientists from six Austrian universities as well as several external partners aimed to identify and characterize natural products capable of combating inflammatory processes specifically in the cardiovascular system. The combined use of computational techniques with traditional knowledge, high-tech chemical analysis and synthesis, and a broad range of in vitro, cell-based, and in vivo pharmacological models led to the identification of a series of promising anti-inflammatory drug lead candidates. Mechanistic studies contributed to a better understanding of their mechanism of action and delivered new knowledge on the molecular level of inflammatory processes. Herein, the used approaches and selected highlights of the results of this interdisciplinary project are presented. GRAPHICAL ABSTRACT: [Image: see text] Springer Vienna 2016-02-25 2016 /pmc/articles/PMC4785209/ /pubmed/27069281 http://dx.doi.org/10.1007/s00706-015-1653-y Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Invited Review Waltenberger, Birgit Atanasov, Atanas G. Heiss, Elke H. Bernhard, David Rollinger, Judith M. Breuss, Johannes M. Schuster, Daniela Bauer, Rudolf Kopp, Brigitte Franz, Chlodwig Bochkov, Valery Mihovilovic, Marko D. Dirsch, Verena M. Stuppner, Hermann Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project |
title | Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project |
title_full | Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project |
title_fullStr | Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project |
title_full_unstemmed | Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project |
title_short | Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project |
title_sort | drugs from nature targeting inflammation (dnti): a successful austrian interdisciplinary network project |
topic | Invited Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785209/ https://www.ncbi.nlm.nih.gov/pubmed/27069281 http://dx.doi.org/10.1007/s00706-015-1653-y |
work_keys_str_mv | AT waltenbergerbirgit drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT atanasovatanasg drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT heisselkeh drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT bernharddavid drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT rollingerjudithm drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT breussjohannesm drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT schusterdaniela drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT bauerrudolf drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT koppbrigitte drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT franzchlodwig drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT bochkovvalery drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT mihovilovicmarkod drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT dirschverenam drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject AT stuppnerhermann drugsfromnaturetargetinginflammationdntiasuccessfulaustrianinterdisciplinarynetworkproject |